Boston, MA -- (SBWIRE) -- 08/23/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Cypress Semiconductor Corporation (NASDAQ:CY), Sonus Networks, Inc.(NASDAQ:SONS), Children's Place Retail Stores, Inc. (NASDAQ:PLCE), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
Cypress Semiconductor Corporation (NASDAQ:CY) stock increased 1.29% to $11.79. The company on August 5 announced that its Board of Directors has approved a quarterly cash dividend of $0.11 per share payable to holders of record of the Company's common stock at the close of business on September 26, 2013. This dividend will be paid on October 17, 2013.
How Should Investors Trade CY After The Recent Volatility? Get Free Report Here
Sonus Networks, Inc.(NASDAQ:SONS) shares gained 1.80% to $3.40. The company, on July 29, announced results for the second quarter ended June 28, 2013. Sonus also announced that its Board of Directors has approved a stock buyback program of up to $100 million.
Revenue for the second quarter of 2013 was $69.2 million, compared to $57.6 million in the second quarter of 2012. The GAAP net loss for the second quarter of 2013 was $4.9 million, or $0.02 per share, compared to a GAAP net loss of $11.7 million, or $0.04 per share, in the second quarter of 2012. Non-GAAP net income for the second quarter of 2013 was $3.2 million, or $0.01 per diluted share, compared to a non-GAAP net loss of $8.6 million, or $0.03 per share, in the second quarter of 2012.
How Should Investors Trade SONS After The Recent Volatility? Get Free Report Here
Children's Place Retail Stores, Inc. (NASDAQ:PLCE) shares gained 6.19% to $54.58. The company on August 22 posted a wider second-quarter net loss of $23.64 million, or $1.05 per share, compared with a $17.92 million, or $0.74 per share loss, in the previous year. Adjusted net loss was $9.43 million, or $0.42 per share for the latest period. Analysts expected loss per share of $0.53 for the quarter. Net sales in the quarter increased 6.0% year-over-year to $382.45 million, from $360.83 million. Analysts estimated revenues of $381.06 million.
Is PLCE A Good Buy After The Recent Price Movement? Find Out Here
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) shares increased 1.36% to $11.21. The company on August 21 announced that Michael Hall, MB. BCh., has joined the company as senior vice president of clinical development. Dr. Hall will lead Ironwood's clinical research, clinical development, clinical operations, biostatistics and pharmacovigilance teams. In this role, he will oversee clinical trials investigating additional appropriate populations for linaclotide, as well as Ironwood's pipeline of early development candidates.
Is IRWD A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)